These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

349 related items for PubMed ID: 16496379

  • 1. L-type amino acid transporter 1 as a potential molecular target in human astrocytic tumors.
    Nawashiro H, Otani N, Shinomiya N, Fukui S, Ooigawa H, Shima K, Matsuo H, Kanai Y, Endou H.
    Int J Cancer; 2006 Aug 01; 119(3):484-92. PubMed ID: 16496379
    [Abstract] [Full Text] [Related]

  • 2. System L-amino acid transporters are differently expressed in rat astrocyte and C6 glioma cells.
    Kim DK, Kim IJ, Hwang S, Kook JH, Lee MC, Shin BA, Bae CS, Yoon JH, Ahn SG, Kim SA, Kanai Y, Endou H, Kim JK.
    Neurosci Res; 2004 Dec 01; 50(4):437-46. PubMed ID: 15567481
    [Abstract] [Full Text] [Related]

  • 3. Enhanced tumor growth elicited by L-type amino acid transporter 1 in human malignant glioma cells.
    Kobayashi K, Ohnishi A, Promsuk J, Shimizu S, Kanai Y, Shiokawa Y, Nagane M.
    Neurosurgery; 2008 Feb 01; 62(2):493-503; discussion 503-4. PubMed ID: 18382329
    [Abstract] [Full Text] [Related]

  • 4. High expression of L-type amino acid transporter 1 in infiltrating glioma cells.
    Nawashiro H, Otani N, Uozumi Y, Ooigawa H, Toyooka T, Suzuki T, Katoh H, Tsuzuki N, Ohnuki A, Shima K, Shinomiya N, Matsuo H, Kanai Y.
    Brain Tumor Pathol; 2005 Feb 01; 22(2):89-91. PubMed ID: 18095110
    [Abstract] [Full Text] [Related]

  • 5. Correlation of L-methyl-11C-methionine (MET) uptake with L-type amino acid transporter 1 in human gliomas.
    Okubo S, Zhen HN, Kawai N, Nishiyama Y, Haba R, Tamiya T.
    J Neurooncol; 2010 Sep 01; 99(2):217-25. PubMed ID: 20091333
    [Abstract] [Full Text] [Related]

  • 6. The role of CD98 in astrocytic neoplasms.
    Nawashiro H, Otani N, Shinomiya N, Fukui S, Nomura N, Yano A, Shima K, Matsuo H, Kanai Y.
    Hum Cell; 2002 Mar 01; 15(1):25-31. PubMed ID: 12126061
    [Abstract] [Full Text] [Related]

  • 7. Expression cloning and characterization of a transporter for large neutral amino acids activated by the heavy chain of 4F2 antigen (CD98).
    Kanai Y, Segawa H, Miyamoto Ki, Uchino H, Takeda E, Endou H.
    J Biol Chem; 1998 Sep 11; 273(37):23629-32. PubMed ID: 9726963
    [Abstract] [Full Text] [Related]

  • 8. Differential expression and functional characterization of system L amino acid transporters in human normal osteoblast cells and osteogenic sarcoma cells.
    Kim SG, Kim HH, Kim HK, Kim CH, Chun HS, Kanai Y, Endou H, Kim DK.
    Anticancer Res; 2006 Sep 11; 26(3A):1989-96. PubMed ID: 16827134
    [Abstract] [Full Text] [Related]

  • 9. L-type amino acid transporter-1 expressed in human astrocytomas, U343MGa.
    Asano S, Kameyama M, Oura A, Morisato A, Sakai H, Tabuchi Y, Chairoungdua A, Endou H, Kanai Y.
    Biol Pharm Bull; 2007 Mar 11; 30(3):415-22. PubMed ID: 17329830
    [Abstract] [Full Text] [Related]

  • 10. Inhibition of L-type amino acid transporter 1 has antitumor activity in non-small cell lung cancer.
    Imai H, Kaira K, Oriuchi N, Shimizu K, Tominaga H, Yanagitani N, Sunaga N, Ishizuka T, Nagamori S, Promchan K, Nakajima T, Yamamoto N, Mori M, Kanai Y.
    Anticancer Res; 2010 Dec 11; 30(12):4819-28. PubMed ID: 21187458
    [Abstract] [Full Text] [Related]

  • 11. Downregulation of LAT1 expression suppresses cholangiocarcinoma cell invasion and migration.
    Janpipatkul K, Suksen K, Borwornpinyo S, Jearawiriyapaisarn N, Hongeng S, Piyachaturawat P, Chairoungdua A.
    Cell Signal; 2014 Aug 11; 26(8):1668-79. PubMed ID: 24726839
    [Abstract] [Full Text] [Related]

  • 12. System L amino acid transporter inhibitor enhances anti-tumor activity of cisplatin in a head and neck squamous cell carcinoma cell line.
    Yamauchi K, Sakurai H, Kimura T, Wiriyasermkul P, Nagamori S, Kanai Y, Kohno N.
    Cancer Lett; 2009 Apr 08; 276(1):95-101. PubMed ID: 19058911
    [Abstract] [Full Text] [Related]

  • 13. Expression and functional characterization of the system L amino acid transporter in KB human oral epidermoid carcinoma cells.
    Yoon JH, Kim YB, Kim MS, Park JC, Kook JK, Jung HM, Kim SG, Yoo H, Ko YM, Lee SH, Kim BY, Chun HS, Kanai Y, Endou H, Kim DK.
    Cancer Lett; 2004 Mar 18; 205(2):215-26. PubMed ID: 15036654
    [Abstract] [Full Text] [Related]

  • 14. Prognostic significance of L-type amino acid transporter 1 (LAT1) and 4F2 heavy chain (CD98) expression in stage I pulmonary adenocarcinoma.
    Kaira K, Oriuchi N, Imai H, Shimizu K, Yanagitani N, Sunaga N, Hisada T, Ishizuka T, Kanai Y, Nakajima T, Mori M.
    Lung Cancer; 2009 Oct 18; 66(1):120-6. PubMed ID: 19171406
    [Abstract] [Full Text] [Related]

  • 15. Expression of amino acid transporter LAT1 and 4F2hc in the healing process after the implantation of a tooth ash and plaster of Paris mixture.
    Kim SG, Ahn YC, Yoon JH, Kim HK, Park SS, Ahn SG, Endou H, Kanai Y, Park JC, Kim DK.
    In Vivo; 2006 Oct 18; 20(5):591-7. PubMed ID: 17091765
    [Abstract] [Full Text] [Related]

  • 16. Characterization of the system L amino acid transporter in T24 human bladder carcinoma cells.
    Kim DK, Kanai Y, Choi HW, Tangtrongsup S, Chairoungdua A, Babu E, Tachampa K, Anzai N, Iribe Y, Endou H.
    Biochim Biophys Acta; 2002 Sep 20; 1565(1):112-21. PubMed ID: 12225859
    [Abstract] [Full Text] [Related]

  • 17. A new treatment for human malignant melanoma targeting L-type amino acid transporter 1 (LAT1): a pilot study in a canine model.
    Fukumoto S, Hanazono K, Fu DR, Endo Y, Kadosawa T, Iwano H, Uchide T.
    Biochem Biophys Res Commun; 2013 Sep 13; 439(1):103-8. PubMed ID: 23954667
    [Abstract] [Full Text] [Related]

  • 18. Expression of LAT1 predicts risk of progression of transitional cell carcinoma of the upper urinary tract.
    Nakanishi K, Ogata S, Matsuo H, Kanai Y, Endou H, Hiroi S, Tominaga S, Aida S, Kasamatsu H, Kawai T.
    Virchows Arch; 2007 Sep 13; 451(3):681-90. PubMed ID: 17622555
    [Abstract] [Full Text] [Related]

  • 19. L-type amino acid transporter 1 (LAT1): a new therapeutic target for canine mammary gland tumour.
    Fukumoto S, Hanazono K, Komatsu T, Ueno H, Kadosawa T, Iwano H, Uchide T.
    Vet J; 2013 Oct 13; 198(1):164-9. PubMed ID: 23896327
    [Abstract] [Full Text] [Related]

  • 20. Properties of L-type amino acid transporter 1 in epidermal ovarian cancer.
    Kaji M, Kabir-Salmani M, Anzai N, Jin CJ, Akimoto Y, Horita A, Sakamoto A, Kanai Y, Sakurai H, Iwashita M.
    Int J Gynecol Cancer; 2010 Apr 13; 20(3):329-36. PubMed ID: 20375792
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.